Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 5 studies | 23% ± 9% | |
epithelial cell | 4 studies | 30% ± 9% | |
ciliated cell | 4 studies | 24% ± 4% | |
GABAergic neuron | 4 studies | 22% ± 5% | |
classical monocyte | 3 studies | 20% ± 3% | |
non-classical monocyte | 3 studies | 19% ± 3% | |
retinal ganglion cell | 3 studies | 54% ± 25% | |
pericyte | 3 studies | 18% ± 3% | |
smooth muscle cell | 3 studies | 19% ± 1% | |
abnormal cell | 3 studies | 24% ± 5% | |
macrophage | 3 studies | 22% ± 3% | |
glutamatergic neuron | 3 studies | 31% ± 9% | |
dendritic cell | 3 studies | 28% ± 3% | |
basal cell | 3 studies | 29% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 21% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4075.91 | 1445 / 1445 | 100% | 74.54 | 183 / 183 |
kidney | 100% | 3956.85 | 89 / 89 | 100% | 96.30 | 901 / 901 |
ovary | 100% | 3092.37 | 180 / 180 | 100% | 89.70 | 430 / 430 |
prostate | 100% | 4055.74 | 245 / 245 | 100% | 108.37 | 502 / 502 |
skin | 100% | 4645.15 | 1809 / 1809 | 100% | 148.82 | 472 / 472 |
stomach | 100% | 3048.18 | 359 / 359 | 100% | 64.25 | 286 / 286 |
uterus | 100% | 3754.23 | 170 / 170 | 100% | 86.87 | 459 / 459 |
brain | 100% | 5007.53 | 2640 / 2642 | 100% | 127.52 | 705 / 705 |
thymus | 100% | 3878.18 | 653 / 653 | 100% | 100.31 | 604 / 605 |
breast | 100% | 3624.57 | 459 / 459 | 100% | 107.78 | 1116 / 1118 |
liver | 100% | 2505.19 | 226 / 226 | 100% | 65.06 | 405 / 406 |
intestine | 100% | 3600.30 | 966 / 966 | 100% | 70.96 | 525 / 527 |
bladder | 100% | 4431.48 | 21 / 21 | 100% | 99.33 | 502 / 504 |
lung | 100% | 3361.19 | 577 / 578 | 100% | 100.56 | 1152 / 1155 |
pancreas | 99% | 1985.01 | 326 / 328 | 100% | 93.28 | 178 / 178 |
adrenal gland | 100% | 4682.52 | 258 / 258 | 99% | 124.94 | 228 / 230 |
adipose | 100% | 3660.59 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 117.33 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 65.94 | 29 / 29 |
muscle | 100% | 4800.19 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3220.91 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 78.49 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 95.43 | 1 / 1 |
blood vessel | 100% | 4289.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3780.25 | 853 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 76% | 1593.80 | 708 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000434 | Biological process | regulation of protein neddylation |
GO_0045116 | Biological process | protein neddylation |
GO_0000338 | Biological process | protein deneddylation |
GO_0010387 | Biological process | COP9 signalosome assembly |
GO_0008180 | Cellular component | COP9 signalosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | COPS7A |
Protein name | COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (Dermal papilla-derived protein 10) (JAB1-containing signalosome subunit 7a) COP9 signalosome subunit 7A COP9 constitutive photomorphogenic homolog subunit 7A (Arabidopsis), isoform CRA_b (COP9 signalosome subunit 7A) COPS7A protein |
Synonyms | DERP10 CSN7A hCG_25925 |
Description | FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . FUNCTION: Component of the COP9 signalosome complex (CSN), a complex involved in various cellular and developmental processes. The CSN complex is an essential regulator of the ubiquitin (Ubl) conjugation pathway by mediating the deneddylation of the cullin subunits of SCF-type E3 ligase complexes, leading to decrease the Ubl ligase activity of SCF-type complexes such as SCF, CSA or DDB2. The complex is also involved in phosphorylation of p53/TP53, JUN, I-kappa-B-alpha/NFKBIA, ITPK1 and IRF8/ICSBP, possibly via its association with CK2 and PKD kinases. CSN-dependent phosphorylation of TP53 and JUN promotes and protects degradation by the Ubl system, respectively. . |
Accessions | G3XAP1 ENST00000534947.5 ENST00000546229.5 ENST00000626119.2 F5GYF7 F5H4Z0 ENST00000543939.5 ENST00000544725.5 ENST00000543155.6 F5H3M6 ENST00000538375.5 ENST00000544316.1 ENST00000537022.5 ENST00000539735.5 F5H7C6 F5GXT7 Q567U8 F5H248 ENST00000543170.5 ENST00000536872.5 ENST00000543537.5 ENST00000534877.5 ENST00000455113.6 F5H4U8 ENST00000541866.5 Q9UBW8 ENST00000229251.7 ENST00000538753.5 ENST00000540408.5 ENST00000538410.5 |